BLOOD RESEARCH

The Korean Society of Hematology (대한혈액학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiologic overview of malignant lymphoma

  • Huh, Jooryung (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2012.06.04
  • Accepted : 2012.06.13
  • Published : 2012.06.30
⟨ Previous Next ⟩

Abstract

Malignant lymphoma encompasses a wide variety of distinct disease entities. It is generally more common in developed countries and less common in developing countries. The East Asia region has one of the lowest incidence rates of malignant lymphoma. The incidence of malignant lymphoma around the world has been increasing at a rate of 3-4% over the last 4 decades, while some stabilization has been observed in developed countries in recent years. The reasons behind this lymphoma epidemic are poorly understood, although improving diagnostic accuracy, the recent AIDS epidemic, an aging world population and the increasing adoption of cancer-causing behaviors are suggested as contributing factors. Etiologies of malignant lymphoma include infectious agents, immunodeficiency, autoimmune disease, exposure to certain organic chemicals, and pharmaceuticals. The distribution of many subtypes exhibit marked geographic variations. Compared to the West, T/natural killer (NK) cell lymphomas (T/NK-cell lymphoma) and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) are relatively more common, whereas other B-cell lymphomas, particularly follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, are less common in Asia. Some subtypes of T/NK-cell lymphomas defined by Epstein-Barr virus association are predominantly Asian diseases, if not exclusively so. Both ethnic and environmental factors play roles in such diversity. In this review, we discuss the geographic distribution and etiology of malignant lymphoma, as well as the trend.

Keywords

Cited by

  1. 오수유부자이중탕(吳茱萸附子理中湯) 및 거풍산(祛風散)으로 발열, 통증, 전신활동도, 두통 호전을 보인 소음인 말초성 T세포 림프종 환자 1례 vol.24, pp.4, 2012, https://doi.org/10.7730/jscm.2012.24.4.100
  2. Unusual Presentation of Ewing Sarcoma in the Adrenal Gland: A Secondary Malignancy from a Survivor of Burkitt Lymphoma vol.43, pp.6, 2012, https://doi.org/10.1093/jjco/hyt047
  3. Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group vol.6, pp.1, 2012, https://doi.org/10.1186/1756-8722-6-86
  4. Helicobacter pylori -related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity vol.4, pp.None, 2014, https://doi.org/10.1038/bcj.2014.40
  5. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population vol.59, pp.5, 2012, https://doi.org/10.1038/jhg.2014.19
  6. Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy vol.105, pp.12, 2012, https://doi.org/10.1111/cas.12544
  7. Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia vol.7, pp.None, 2012, https://doi.org/10.2147/ott.s67380
  8. Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma vol.55, pp.9, 2012, https://doi.org/10.3109/10428194.2013.871279
  9. Occupational extremely low-frequency magnetic field exposure and selected cancer outcomes in a prospective Dutch cohort vol.25, pp.2, 2012, https://doi.org/10.1007/s10552-013-0322-x
  10. Impact of Inadequate Doses of Rituximab in the Treatment of Diffuse Large B Cell Lymphoma in Malaysian Patients vol.15, pp.4, 2012, https://doi.org/10.7314/apjcp.2014.15.4.1703
  11. EZH2 Mutations in Follicular Lymphoma from Different Ethnic Groups and Associated Gene Expression Alterations vol.20, pp.12, 2012, https://doi.org/10.1158/1078-0432.ccr-13-1597
  12. Age‐associated Epstein–Barr virus‐specific T cell responses in seropositive healthy adults vol.177, pp.1, 2014, https://doi.org/10.1111/cei.12337
  13. Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis vol.47, pp.2, 2012, https://doi.org/10.4143/crt.2014.055
  14. Tendência de mortalidade por linfomas não Hodgkin no Brasil, 1980 a 2012 vol.23, pp.2, 2012, https://doi.org/10.1590/1414-462x201500020014
  15. Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis vol.47, pp.3, 2012, https://doi.org/10.4143/crt.2014.034
  16. Epstein–Barr virus‐specific CD8+ T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired vol.182, pp.2, 2012, https://doi.org/10.1111/cei.12682
  17. Neuropathies associated with lymphoma† vol.2, pp.4, 2015, https://doi.org/10.1093/nop/npv025
  18. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy vol.31, pp.3, 2012, https://doi.org/10.3904/kjim.2014.222
  19. Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism vol.48, pp.1, 2012, https://doi.org/10.4143/crt.2014.266
  20. Clonal deleted latent membrane protein 1 variants of Epstein‐Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment vol.139, pp.4, 2016, https://doi.org/10.1002/ijc.30128
  21. Relationship Between Dual Time Point FDG PET/CT and Clinical Prognostic Indexes in Patients with High Grade Lymphoma: a Pilot Study vol.51, pp.4, 2012, https://doi.org/10.1007/s13139-017-0480-y
  22. Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL vol.129, pp.2, 2012, https://doi.org/10.1182/blood-2016-04-713719
  23. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma vol.14, pp.4, 2012, https://doi.org/10.1080/14789450.2017.1307106
  24. Malignant lymphoma on parotid gland: a clinical case vol.43, pp.2, 2012, https://doi.org/10.5125/jkaoms.2017.43.2.138
  25. Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model vol.9, pp.2, 2012, https://doi.org/10.18632/oncotarget.23156
  26. Epidemiology and Patterns of Malignant Lymphoma in Northern Saudi Arabia vol.8, pp.4, 2012, https://doi.org/10.4236/ojbd.2018.84009
  27. Distribution of lymphomas in Mexico: a multicenter descriptive study vol.11, pp.4, 2012, https://doi.org/10.1007/s12308-018-0336-0
  28. Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin vol.8, pp.None, 2012, https://doi.org/10.1038/s41598-018-21645-x
  29. ACOX1 destabilizes p73 to suppress intrinsic apoptosis pathway and regulates sensitivity to doxorubicin in lymphoma cells vol.52, pp.9, 2012, https://doi.org/10.5483/bmbrep.2019.52.9.094
  30. Malignancy in common variable immunodeficiency: a systematic review and meta-analysis vol.15, pp.10, 2019, https://doi.org/10.1080/1744666x.2019.1658523
  31. Emergence of a lymphoma imitating an infectious infiltration surrounding the infrarenal aorta after EVAR vol.48, pp.6, 2019, https://doi.org/10.1024/0301-1526/a000806
  32. Pattern of Non-Hodgkin Lymphoma in a Tertiary Care Center in Northeast India Using Morphology and Immunohistochemistry vol.40, pp.4, 2019, https://doi.org/10.4103/ijmpo.ijmpo_129_18
  33. Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI: Imaging Appearances and Clinical Importance vol.40, pp.1, 2020, https://doi.org/10.1148/rg.2020190037
  34. Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma vol.13, pp.4, 2012, https://doi.org/10.1080/17474086.2020.1733405
  35. COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence vol.141, pp.None, 2012, https://doi.org/10.1016/j.fct.2020.111418
  36. Validación de la escala FACT-Lym para la evaluación de la calidad de vida en pacientes colombianos con linfoma vol.68, pp.3, 2012, https://doi.org/10.15446/revfacmed.v68n3.75693
  37. Granulocyte radiolabeling using Leukokit® with introduction of a density gradient medium as ancillary material vol.64, pp.3, 2012, https://doi.org/10.23736/s1824-4785.19.03073-5
  38. Rituximab-induced acute thrombocytopenia in patients with splenomegaly B Cell lymphoma: an underdiagnosed but severe complication vol.21, pp.11, 2012, https://doi.org/10.1080/15384047.2020.1832017
  39. Prevalence and diagnostic challenges of thyroid lymphoma: a multi-institutional study in non-Western countries vol.67, pp.11, 2012, https://doi.org/10.1507/endocrj.ej20-0202
  40. Clinical features and outcomes from the Singapore Sjögren's syndrome study vol.30, pp.2, 2021, https://doi.org/10.1177/0961203320976932
  41. Canine lymphoma and vector‐borne diseases: Molecular and serological evaluation of a possible complicity vol.19, pp.1, 2021, https://doi.org/10.1111/vco.12658
  42. Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan vol.35, pp.7, 2012, https://doi.org/10.1038/s41433-020-01198-y
  43. Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy vol.205, pp.1, 2012, https://doi.org/10.1111/cei.13592
  44. Oral and oropharyngeal lymphomas: A multi‐institutional collaborative study vol.50, pp.6, 2012, https://doi.org/10.1111/jop.13211
  45. Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015 vol.21, pp.8, 2012, https://doi.org/10.1016/j.clml.2021.03.010
  46. Spectrum of common Hodgkin lymphoma and non-Hodgkin lymphomas subtypes in Zambia: a 3-year records review vol.40, pp.1, 2012, https://doi.org/10.1186/s41043-021-00261-y
  47. Spectrum of lymphoma subtypes based on the latest World Health Organization classification in southern Iran from 2000 to 2011 vol.17, pp.34, 2012, https://doi.org/10.2217/fon-2020-0534